T
TOBAM Portfolio holdings
AUM
$256M
1-Year Return
13.59%
This Quarter Return
-6.06%
1 Year Return
+13.59%
3 Year Return
+36.98%
5 Year Return
+80%
10 Year Return
+220.89%
AUM
$1.43B
AUM Growth
-$165M
(-10%)
Cap. Flow
-$65.5M
Cap. Flow
% of AUM
-4.58%
Top 10 Holdings %
Top 10 Hldgs %
25.47%
Holding
484
New
55
Increased
94
Reduced
160
Closed
54
Top Buys
| 1 |
DaVita
DVA
|
$11.5M |
| 2 |
AbbVie
ABBV
|
$9.68M |
| 3 |
Baxter International
BAX
|
$9.64M |
| 4 |
Johnson & Johnson
JNJ
|
$8.77M |
| 5 |
Bristol-Myers Squibb
BMY
|
$8.09M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$15.9M |
| 2 |
Electronic Arts
EA
|
$15.7M |
| 3 |
Biogen
BIIB
|
$11.4M |
| 4 |
Domino's
DPZ
|
$9.79M |
| 5 |
Lyft
LYFT
|
$9.44M |
Sector Composition
| 1 | Healthcare | 30.56% |
| 2 | Consumer Staples | 25.79% |
| 3 | Communication Services | 7.82% |
| 4 | Materials | 7.12% |
| 5 | Technology | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Verizon
VZ
$186B
| $19.9M | 1.39% |
523,379
+148,719
| +40% | +$5.65M |
|
|
27
Electronic Arts
EA
$42B
| $18.8M | 1.31% |
162,561
-135,769
| -46% | -$15.7M |
|
28
Moderna
MRNA
$9.45B
| $17.9M | 1.25% |
151,252
+4,481
| +3% | +$530K |
|
|
29
DaVita
DVA
$9.69B
| $17.2M | 1.2% |
207,290
+139,414
| +205% | +$11.5M |
|
30
EOG Resources
EOG
$66.4B
| $16.5M | 1.16% |
148,117
+11,839
| +9% | +$1.32M |
|
31
Kroger
KR
$44.9B
| $16.5M | 1.15% |
376,419
-24,684
| -6% | -$1.08M |
|
|
32
AbbVie
ABBV
$376B
| $16.2M | 1.13% |
120,456
+72,131
| +149% | +$9.68M |
|
33
Cboe Global Markets
CBOE
$24.5B
| $16.1M | 1.12% |
136,865
+23,797
| +21% | +$2.79M |
|
34
SolarEdge
SEDG
$2.03B
| $15.5M | 1.08% |
67,019
+6,654
| +11% | +$1.54M |
|
35
Schlumberger
SLB
$53.7B
| $15M | 1.05% |
418,479
+33,263
| +9% | +$1.19M |
|
36
Franco-Nevada
FNV
$36.6B
| $14.5M | 1.02% |
120,894
-48,419
| -29% | -$5.82M |
|
37
CF Industries
CF
$13.6B
| $14.5M | 1.01% |
150,804
+48,156
| +47% | +$4.64M |
|
38
Take-Two Interactive
TTWO
$44.4B
| $14M | 0.98% |
128,460
+8,801
| +7% | +$959K |
|
39
EPAM Systems
EPAM
$9.36B
| $13.7M | 0.96% |
37,760
-9,287
| -20% | -$3.36M |
|
40
Gilead Sciences
GILD
$140B
| $13.2M | 0.92% |
213,687
-85,283
| -29% | -$5.26M |
|
41
Dentsply Sirona
XRAY
$2.86B
| $13M | 0.91% |
458,977
-31,757
| -6% | -$900K |
|
|
PARA
42
DELISTED
Paramount Global Class B
PARA
| $12.5M | 0.88% |
658,540
-175,740
| -21% | -$3.35M |
|
43
Burlington
BURL
$19B
| $12.4M | 0.87% |
111,150
+21,205
| +24% | +$2.37M |
|
|
44
Johnson & Johnson
JNJ
$431B
| $11.8M | 0.83% |
72,528
+53,659
| +284% | +$8.77M |
|
45
Snap
SNAP
$12B
| $11.6M | 0.81% |
1,180,706
+261,573
| +28% | +$2.57M |
|
46
Lucid Motors
LCID
$4.97B
| $11.1M | 0.77% |
79,225
+16,066
| +25% | +$2.24M |
|
47
McCormick & Company Non-Voting
MKC
$18.8B
| $11.1M | 0.77% |
155,226
+37,368
| +32% | +$2.66M |
|
48
Conagra Brands
CAG
$9.07B
| $11M | 0.77% |
337,472
-190,234
| -36% | -$6.21M |
|
49
Regeneron Pharmaceuticals
REGN
$60.1B
| $9.68M | 0.68% |
14,055
-3,959
| -22% | -$2.73M |
|
|
50
Bristol-Myers Squibb
BMY
$95B
| $9.3M | 0.65% |
130,797
+113,765
| +668% | +$8.09M |
|